US Stock MarketDetailed Quotes

NYMXF Nymox Pharmaceutical

Watchlist
  • 0.090
  • 0.0000.00%
15min DelayTrading Feb 19 11:01 ET
8.42MMarket Cap-0.90P/E (TTM)

About Nymox Pharmaceutical Company

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

Company Profile

SymbolNYMXF
Company NameNymox Pharmaceutical
Listing DateNov 26, 1997
Founded1995
CEODr. Paul Averback,M.D.,D.A.B.P.
MarketPink Market
Employees9
Fiscal Year Ends12-31
AddressBay & Deveaux Streets,2nd Floor
CityNassau
ProvinceNew Providence
CountryBahamas (the)
Phone1-800-936-9669

Company Executives

  • Name
  • Position
  • Salary
  • PatrickA. Doody
  • Vice President and General Counsel
  • --
  • Paul Averback
  • President and Director
  • --
  • James G. Robinson
  • Director
  • --
  • David Morse
  • Director
  • --
  • Suresh Kalbag
  • Director
  • --
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.